Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection

Digestive and Liver Disease

Volumn 35, Issue 11, 2003, Pages 801-805

  Bogdanos, D P ^a   Baum, H ^b   Butler, P ^c   Rigopoulou, E I ^d   Davies, E T ^b   Ma, Y ^a   Burroughs, A K ^c   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

Autoantibody; Autoimmunity; Biliary; Liver; Mimicry

Indexed keywords

ANTINUCLEAR ANTIBODY; GLYCOPROTEIN; GLYCOPROTEIN GP 210; LAMIN B; MITOCHONDRION ANTIBODY; NUCLEOPORIN; PROTEIN ANTIBODY; PROTEIN SP100; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; AUTOANTIBODY; CELL NUCLEUS ANTIGEN;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOREACTIVITY; PRIMARY BILIARY CIRRHOSIS; RECURRENT INFECTION; SERODIAGNOSIS; URINARY TRACT INFECTION; BILIARY CIRRHOSIS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; LIVER MITOCHONDRION; MIDDLE AGED; RECURRENT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; MITOCHONDRIA, LIVER; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 1542389147     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00466-3     Document Type: Article

References (34)

1. Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta 1995;1271:111-21.
2. Haydon GH, Neuberger J. PBC: an infectious disease? Gut 2000; 47:586-8.
3. Joplin R. Thoughts on the infectious aetiology of primary biliary cirrhosis. In: Manns MP, Paumgartner U, Leuschner U, editors. Falk Symposium 114, Immunology and Liver. Dordrecht: Kluwer Academic Publishers, 2000, p. 268-78.
4. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995;181:1835-45.
5. Mayo I, Arizti P, Pares A, Oliva J, Doforno RA, de Sagarra MR, et al. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol 2000;33:528-36.
6. Baum H, Bogdanos DP, Vergani D. Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. J Hepatol 2001;34:785-7.
7. Bogdanos DP, Baum H, Sharma UC, Grasso A, Ma Y, Burroughs AK, et al. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 2002;36:14-21.
8. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-80.
9. Neuberger J. Primary biliary cirrhosis. Lancet 1997;350:875-9.
10. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; in press.
11. Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut 1984;25:133-7.
12. Butler P, Hamilton-Miller JM, McIntyre N, Burroughs AK. Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups. Gut 1995;36:931-4.
13. Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol 1993;17:408-14.
14. Morreale M, Tsirigotis M, Hughes MD, Brumfitt W, McIntyre N, Burroughs AK. Significant bacteriuria has prognostic significance in primary biliary cirrhosis. J Hepatol 1989;9:149-58.
15. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 2001;33:16-21.
16. Butler P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int 1995;35:473-85.
17. Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:79-90.
18. Szostecki C, Guldner HH, Will H. Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin Liver Dis 1997;17:71-8.
19. Zuchner D, Sternsdorf T, Szostecki C, Heathcote EJ, Cauch-Dudek K, Will H. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 1997;26:1123-30.
20. Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998;13:257-65.
21. Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001;34:366-72.
22. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003;98:431-7.
23. Vergani D, Bogdanos DP. Positive markers in AMA-negative PBC. Am J Gastroenterol 2003;98:241-3.
24. Baum H, Butler P, Davies H, Sternberg MJ, Burroughs AK. Autoimmune disease and molecular mimicry: an hypothesis. Trends Biochem Sci 1993;18:140-4.
25. Burroughs AK, Butler P, Sternberg MJ, Baum H. Molecular mimicry in liver disease. Nature 1992;358:377-8.
26. Bogdanos DP, Grasso A, Okamoto M, Montalto P, Butler P, Williams R, et al. Cross-reactivity to Lactobacillus delbrueckii /human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis. Hepatology 2000;32:300A.
27. Bogdanos DP, Pares A, Sharma UC, Caballeria L, Ma Y, Burroughs AK, et al. Crossreactivity between mycobacterium gordonae and PDC-E2, the major target of antimitochondrial antibody, is present in Spanish but not British patients with primary biliary cirrhosis. J Hepatol 2001;34:19.
28. Ishibashi H, Kamihira T, Shimoda S. Bile duct cell apoptosis: a rare event in primary biliary cirrhosis? Dig Liver Dis 2001;33:122-4.
29. Marucci L, Ugili L, Macarri G, Feliciangeli G, Bendia E, Jezequel AM, et al. Primary biliary cirrhosis: modalities of injury and death in biliary epithelium. Dig Liver Dis 2001;33:576-83.
30. Marzioni M, Glaser SS, Alpini G, LeSage GD. Role of apoptosis in development of primary biliary cirrhosis. Dig Liver Dis 2001;33: 531-3.
31. Shimoda S, Nakamura M, Ishibashi H, Kawano A, Kamihira T, Sakamoto N, et al. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 2003;124:1915-25.
32. Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001;21:225-32.
33. Bogdanos DP, Mieli-Vergani G, Vergani D. Virus, liver and autoimmunity. Dig Liver Dis 2000;32:440-6.
34. Van de Water J, Ishibashi H, Coppel RL, Gershwin ME. Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology 2001;33:771-5.